Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

Abstract

Statin use was associated with a reduced risk of HCC development in chronic HBV-infected patients, suggesting that statins may have a chemopreventive role in this population. These findings warrant a prospective evaluation.